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Microarray analysisThe inner ear epithelium, with its complex array of sensory, non-sensory, and neuronal cell types necessary for
hearing and balance, is derived from a thickened patch of head ectoderm called the otic placode. Mouse
embryos lacking both Fgf3 and Fgf10 fail to initiate inner ear development because appropriate patterns of gene
expression fail to be speciﬁedwithin the pre-otic ﬁeld. To understand the transcriptional “blueprint” initiating
inner ear development, we used microarray analysis to identify prospective placode genes that were dif-
ferentially expressed in control and Fgf3−/−;Fgf10−/− embryos. Several genes in the down-regulated class,
including Hmx3, Hmx2, Foxg1, Sox9, Has2, and Slc26a9were validated by in situ hybridization. We also assayed
candidate target genes suggested by other studies of otic induction. Two placodemarkers, Fgf4 and Foxi3, were
down-regulated in Fgf3−/−;Fgf10−/− embryos, whereas Foxi2, a cranial epidermis marker, was expanded in
double mutants, similar to its behavior when WNT responses are blocked in the otic placode. Assays of hind-
brainWnt genes revealed that onlyWnt8awas reduced or absent in FGF-deﬁcient embryos, and that even some
Fgf3−/−;Fgf10−/+ and Fgf3−/− embryos failed to expressWnt8a, suggesting a key role for Fgf3, and a secondary
role for Fgf10, in Wnt8a expression. Chick explant assays showed that FGF3 or FGF4, but not FGF10, were
sufﬁcient to induceWnt8a. Collectively, our results suggest thatWnt8a provides the link between FGF-induced
formation of the pre-otic ﬁeld and restriction of the otic placode to ectoderm adjacent to the hindbrain.etics, University of Utah, 15 N
1 801 581 7796.
L. Mansour).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The inner ear is one of the most sophisticated vertebrate sensory
organs, relaying both acoustical and motion/balance information to
the brain. The entire structure, its intricate auditory and vestibular
compartments, and innervating neurons, develops from the otic
placode, a localized thickening of the caudalmost cranial ectoderm.
All vertebrate cranial sensory organs derive from ectodermal placodes.
Evidence suggests that these placodes emerge from a common ‘pan-
placodal ﬁeld’ that, shortly after gastrulation, surrounds the develop-
ing cranial neural plate in a narrow, horseshoe-shaped band. This ﬁeld
is deﬁned as a distinct entity based on a characteristic set of expressed
genes, includingmembers of theDlx, Eya, and Six gene families (Ohyama,
2009; Ohyama et al., 2007; Schlosser, 2006; Streit, 2007).
To form speciﬁc sensory placodes, the ectoderm must ﬁrst acquire
competence to respond to inductive signals (Groves and Bronner-
Fraser, 2000). Many of the genes expressed in the pan-placodal ﬁeld
are transcription factors that may act individually or combinatorially
as competence factors, preparing the ectoderm to receive subsequentinductive signals from the surrounding tissues (Martin and Groves,
2006; Schlosser and Ahrens, 2004). After acquiring competence,
a second step in placode development is a differential response of
competent pre-placodal ectoderm to a unique code of local inducing
signals that specify particular placode identity along the anteropos-
terior axis of the head. Thus, placode induction consists of a series of
consecutive inductive events rather than binary fate assignments
(Jacobson, 1966; McCabe and Bronner-Fraser, 2009; Ohyama, 2009;
Ohyama et al., 2007; Schlosser, 2006). Much effort is focused on
elucidating the nature of these signals and the transcriptional effec-
tors they, in turn, activate within the target ectoderm to induce the
subsequent development of a given placode.
Fibroblast growth factor (FGF) family members play pivotal roles
in inner ear induction in several species, although the identity and
sources of the FGFs often differ among species (Ohyama et al., 2007;
Schimmang, 2007; Wright and Mansour, 2003b). Our studies and
others showed that FGF3 and FGF10 are the most proximal signals
that induce otic placodal fate in mice. Both factors are expressed near
the pre-otic ﬁeld (in the hindbrain and mesenchyme, respectively) at
the time of otic placode induction, and mice lacking both Fgf3 and
Fgf10 either fail to form otic vesicles altogether, or form microvesicles
that do not differentiate into ear structures (Alvarez et al., 2003;
Wright and Mansour, 2003a). Similarly, chick Fgf3 and Fgf19 are
required for expression of otic placode marker genes (Freter et al.,
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chick, functioning indirectly to induce mesodermal Fgf10 in mouse
and Fgf19 in chick (Ladher et al., 2005; Zelarayan et al., 2007).
Ladher et al. (2000) ﬁrst reported the involvement of hindbrain
WNT signaling, in addition to FGF signaling, in chick otic placode
induction. Exposing explants of presumptive chick otic ectodermwith
WNT8A (previously called WNT8C)-expressing cells and FGF19-
soaked beads resulted in the expression of several otic markers,
whereas neither factor alone was sufﬁcient. By studying transgenic
TCF/Lef-lacZ reporter mice, Ohyama et al. (2006) found that WNT
signaling is received by a subset of cells within the pre-otic ﬁeld, those
that residemost proximal to the neural tube, whereas themore lateral
ectoderm displays little or no reporter activity. Importantly, they
found thatWNT signaling plays a role in reﬁning the ventral boundary
of the otic placode within the larger Pax2+ pre-otic ﬁeld that is
initially established by FGF induction and encompasses both the
prospective otic placode and the ventrolateral ectoderm that has
epibranchial placode and epidermal fates. Conditional inactivation
of ß-catenin, a key effector of canonical WNT signaling, resulted in
the formation of smaller otic vesicles and expanded the non-otic
ectoderm. In contrast, constitutive activation of WNT signaling using
activated ß-catenin, caused an expansion of the otic domain at
the expense of non-otic ectodermal fates. Similarly, in chick, DKK1-
mediated inhibition of ectodermal WNT signaling, or expression of
activated ß-catenin, caused reduction or expansion, respectively, of
the otic domain (Freter et al., 2008). These data suggest that WNT
signaling modulates the otic placode–non-otic ectoderm fate deci-
sion and, as such, represents a third incremental step in the spec-
iﬁcation of the otic placode. It remains to be determined which WNT
molecule(s) are required in vivo, and whether the FGF and WNT
signals act in series or in parallel to instruct and reﬁne placode
induction.
To gain insight into these questions and to begin to understand the
FGF-induced genetic program, or “blueprint”, for otic development,
we isolated by microdissection the prospective otic ectoderm from
control and Fgf3−/−;Fgf10−/− embryos at the time of otic induction
(4–8 somite-stages). We subjected the RNA to microarray analysis
to identify ectodermal genes that were differentially expressed, and
found a small set of prospective targets. Several genes in the down-
regulated class were validated by in situ hybridization. Among these
were several transcription factor-encoding genes required at later
stages of otic development, but not previously associatedwith placode
induction in the mouse. Two additional validated targets, Has2 and
Slc26a9, are novel candidates for genes thatmay play roles in inner ear
development at inductive or later stages. We also assayed candidate
genes suggested by other studies of otic induction, including those
described above. Two placode markers, Fgf4 and Foxi3, were down-
regulated in Fgf3−/−;Fgf10−/− embryos, whereas Foxi2, a cranial epi-
dermis marker, was expanded in the double mutants, similar to its
behavior whenWNT signaling is blocked in the otic placode. Assays of
hindbrainWnt genes revealed that onlyWnt8awas reduced or absent
in FGF-deﬁcient embryos, and that even some Fgf3−/−;Fgf10+/− and
Fgf3−/− embryos failed to express Wnt8a, suggesting a key role for
Fgf3, and a secondary role for Fgf10, in maintainingWnt8a. Moreover,
chick explant assays showed that FGF3 and FGF4, but not FGF10, were
sufﬁcient to induceWnt8a. Taken together, our results show that FGF
signaling is both necessary and sufﬁcient to induceWnt8a, and suggest
that Wnt8a expression links FGF-induced formation of the pre-otic
ﬁeldwith restriction of the otic placode to the ectodermadjacent to the
hindbrain.Materials and methods
All mouse studies complied with protocols approved by the
University of Utah Institutional Animal Care and Use Committee.Generation of Fgf3 and Fgf10 conditional alleles
Fgf3- and Fgf10-genomic DNA-containing phages were isolated by
recombination cloning from the λKO2 library (Zhang et al., 2002). One
phage bore an approximate 9.0 kb fragment of Fgf3, with a loxP site
located in the intron 3.8 kb downstream of exon 2, and the other
carried an approximate 10.0 kb fragment Fgf10, with a loxP site
located in the intron 0.85 kb downstream of exon 2. After recovery of
the phage inserts, we generated targeting vectors, each of which had a
tetracycline response element (TRE) with or without an antisense
CMV promoter element, followed by loxP and FRT sites, and NeoR and
KanR expression cassettes inserted in an intron 0.58 and 0.30 kb up-
stream of Fgf3 and Fgf10 exon 2, respectively. Each of the four target-
ing vectors was linearized and electroporated into R1–45 ES cells,
which were selected in G-418 and ganciclovir as described (Li et al.,
2007). Correct homologous recombination between the vectors and
the genome was determined by Southern blot hybridization using 5′
and 3′ probes ﬂanking the targeting sequences. Following introduc-
tion into C57Bl/6 embryos, correctly targeted cell lines generated
highly chimeric males that transmitted the targeted alleles to off-
spring. Phenotypic observations of targeted homozygotes showed
that the initially targeted alleles were hypomorphic (data not shown).
To remove the intronic selection cassettes, heterozygoteswere crossed
to FLPe-expressing mice (Gt(ROSA)26Sortm1(FLP1)Dym, The Jackson
Laboratory [JAX] strain #003946) (Farley et al., 2000). The resulting
conditional strains were veriﬁed by Southern blot hybridization and
PCR analyses (not shown) and have an intronic TRE with or without
an antisense CMV promoter, and exon 2, comprised in both cases of
104 bp, is ﬂanked by loxP sites. These alleles are designated c (no CMV
promoter) or Pc (with the intronic CMV promoter). Each of the four
homozygous conditional strains had normal viability, but Fgf3Pc/Pc
mice invariably showed slight tail kinks—amild version of the Fgf3null
short-tail phenotype (Alvarez et al., 2003; Hatch et al., 2007; Mansour
et al., 1993). All experiments reported here involved the “c” alleles.
For global removal of exon 2, hypomorphic mice were crossed to the
Cre deleter strain, BALB/c-Tg(CMV-cre)1Cgn/J (JAX stock #003465)
(Schwenk et al., 1995). Mice/embryos homozygous for the exon 2
deletions (designated Δ2 alleles) or compound heterozygotes with
establishednull alleles (Fgf3tm1Mrc or Fgf10tm1Wss) (Mansour et al., 1993;
Min et al., 1998) were indistinguishable from the established null
homozygotes (data not shown).Generation and genotyping of Fgf3/Fgf10 global null embryos
Global deletion of both conditional alleles was accomplished
using Hprt1tm1(cre)Mnn (Tang et al., 2002), kindly supplied by M.
Capecchi. Standard genetic crosses were used to generate Fgf3Δ2/+;
Fgf10Δ2/+;HprtCre/+ females, which were crossed to Fgf3c/c;Fgf10c/c
males. Allele-speciﬁc PCR assays for genotyping included the following
primers: Hprt: SLM10 (5′-GCCTGCTTGCCGAATATCATGG-3′), SLM544
(5′-CCTGATTTTATTTCTATAGGACTGAAAGAC-3′), and SLM545 (5′-
TAAGTTAATTATACTTACACAGTAGCTCTTC) produced 200 bp wild-
type and 550 bp Cre insertion allele fragments. Fgf3: SLM608 (5′-
GGACGTATGAACGAGTGTATAGATGG-3′), SLM609 (5′-AGGGATGGTCC-
TACAGACTTGCAG-3″), and SLM485B (5′-GGTTCCTCGATCAAACTCTGG-
3′) produced 615 bp deletion allele and 480 bp conditional allele, and
379 bp wild-type fragments. Fgf10: SLM492B (5′-GTACCGAGCTC-
GACTTTCAC-3′), SLM479B (5′-GTCTTTTTGACTGAAACCTCAC-3′), and
SLM411B (5′-ATCCTTGGGAGGCAGGATAACC-3′) produced 450 bp de-
letion allele, 277 bp conditional allele, and 175 bpwild-type fragments.
Crossing Fgf3Δ2/+;Fgf10Δ2/+;HprtCre/Y males to double conditional
females was compromised by frequent CRE-mediated interchromo-
somal recombination between the similarly oriented loxP sites pres-
ent in the Fgf3Δ2 and Fgf10Δ2 loci, leading to balanced and unbalanced
translocations between chromosomes 7 and 11 (data not shown). Thus,
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females from such males.Otic placode RNA isolation and microarray analysis
Timed matings between Fgf3Δ2/+;Fgf10Δ2/+;HprtCre females and
Fgf3c/c;Fgf10c/c males were initiated, and embryos were harvested
on embryonic day (E)8.5. The yolk sac was collected for genotyping.
The otic region, including the prospective placodal ectoderm, neural
ectoderm, and underlying mesendoderm was dissected from 4–8
somite embryos using tungsten knives. Isolation of placodal ectoderm
was accomplished by modiﬁcation (Y. Saijoh, personal communica-
tion) of the enzymatic procedure described by Hogan et al. (1994).
Brieﬂy, the bilateral “tri-layer” otic region fragments were rinsed in
ice-cold PBS and moved to 50 µl of PT solution (25 mg/ml pancreatin
[Sigma], 5 mg/ml trypsin [Sigma], and 5 mg/ml polyvinylpyrrolidone
MW360 [Sigma] in Tyrode's solution) for 5 min on ice to promote
germ layer separation. The fragments were transferred to ice-cold
HEPES-buffered DMEM with 10% FBS for 2–5 min, then the placodal
ectoderm and associated neural ectoderm were teased away from
the mesendoderm with tungsten needles, and the placodal ectoderm
was freed by resection of the attached neural ectoderm with a tung-
sten knife. The two placodal ectoderm fragments from each embryo
(∼100 µm each) were aspirated into 30 μl RLT buffer (Qiagen Micro-
RNA Easy kit), vortexed for 1 min, and stored at −70 °C. All tissue
isolates were stored separately prior to genotyping.
RNAwas extracted (QiagenMicroRNAEasy kit) from threebiological
replica pools; each comprising 10 Fgf3Δ2/+;Fgf10Δ2/+ or 10 Fgf3Δ2/Δ2;
Fgf10Δ2/Δ2 placodes. After elution, RNA integrity was determined on a
Bioanalyzer (Agilent). Recovery was ∼100 ng/pool. RNA was subjected
to a single linear ampliﬁcation labeling reaction (Fgf3Δ2/+;Fgf10Δ2/+
control with Cy3, and Fgf3Δ2/Δ2;Fgf10Δ2/Δ2 mutant with Cy5) and
hybridized to mouse whole genome microarray slides (Agilent
GPL4134) using the standard Agilent 2-color gene expression
hybridization protocol. Slides were scanned (Agilent G2505B)
at 5 µm resolution using an extended dynamic range protocol, and
images were processed with Agilent Feature Extraction software
9.5.1.1. The Lowess-normalized log2 ratio of Cy3/Cy5 was calculated.
Genes signiﬁcantly up- or down-regulated in all three mutant pools
were identiﬁed by rank products analysis (Breitling et al., 2004). The
full dataset was deposited with GEO (GSE18702).
Riboprobe preparation and in situ hybridization
Digoxigenin-labeled antisense cRNA probes were generated
from plasmids carrying cDNA fragments according to standard pro-
cedures, or following direct PCR ampliﬁcation of 3′ UTRs from geno-
mic DNA (adapted from Ambion Technical Bulletin 154). For the
latter, a 28-base T7 RNA polymerase promoter (5′-GGATCCTAATAC-
GACTCACTATAGGGAG-3′) was incorporated at the 5′ end of the re-
verse primer.
Cloned mouse cDNAs used to prepare riboprobes included Erm
(Li et al., 2007),Wnt8a (Bouillet et al., 1996),Wnt1,Wnt3a, and Hmx3
(Hatch et al., 2007), Spry1 (Minowada et al., 1999), Fgf4 (Wright and
Mansour, 2003b), Sox9 (Wright et al., 1995), and Wnt6 (Gavin et al.,
1990) as described in the cited publications. An 886 bp Has2 3′
UTR clone was purchased from OpenBiosystems (GenBank accession
AI592649, clone #633823).
3′ coding region probes for Foxg1 and Cldn4 were generated by
cloning PCR-ampliﬁed DNA fragments into pCRII-TOPO (Invitrogen).
The amplicons included residues 2615–2976 of Foxg1 (GenBank acces-
sion NM_001160112) and residues 392–749 of Cldn4 (GenBank acces-
sion NM_009903).
Probes for the 3′ UTRs of Foxi3, Foxi2, and Hmx2 were PCR-
ampliﬁed from genomic DNA using T7 promoter-tagged reverseprimers. The primer sequences were: Foxi3 forward primer SLM656:
5′-ACTACAACCCTTTCTCTGGTGGC-3′, reverse primer SLM655:
5′-T7-CGGACTTTGCTCACAGTAATCAAGC-3′; Foxi2 forward primer
SLM648: 5′-GCTTTGGGTTTGCCTTACTTGAC-3′, reverse primer
SLM647: 5′-T7-CAGCACACCAGGTAGGAACAACAC-3′; Hmx2 forward
primer SLM594: 5′-AGAATCGCCGCAACAAGTGG-3′, reverse primer
SLM595: 5′-T7-GAGAGCCTCCCCTTCCAAAATAG-3′; Slc26a9 forward
primer SLM691: 5′-TGACTTCCAGCCTTTAGAGTGAG-3′, reverse primer
SLM692: 5′-T7-CCAGTTTGCCCGAGTTTACATTAG-3′. PCR products of
530, 594, 534, and 554 bp respectively, were directly transcribed using
T7 RNA polymerase.
Whole-mount in situ hybridization was performed on embryos
isolated from timed pregnancies essentially as described (Wilkinson,
1992). Stained embryos were post-ﬁxed in 4% paraformaldehyde,
cryoprotected in 15% sucrose/7.5% gelatin, and cryosectioned at
14 μm (Sechrist et al., 1995).
Collagen gel cultures
The collagen gel matrix for tissue explant culture was made by
mixing on ice, 25 μl of 10× DMEM, 40 μl of 7.5% sodium bicarbonate,
5 μl 1 M HEPES buffer (Invitrogen), and 200 μl of 2.5 mg/ml rat colla-
gen (Roche). The matrix was gently stirred until it reached a pale pink
color and was kept on ice until used.
Hamburger andHamilton (HH) stage 4–5 ectoderm, located rostral
to Hensen's node, and consisting of both neural and non-neural ecto-
derm, was used as the test tissue (region “Et”, Ladher et al., 2000,
Fig. 2). Rostral ectodermal isolates were recombined with 0.1% BSA/
PBS control or 0.25 μM recombinant human FGF (R&D Biosystems)
coated Afﬁ-blue gel beads (Bio-Rad Laboratories) in a 10 μl drop of
collagen gel matrix, which was incubated at 37 °C until the matrix
gelled. Tissue/bead recombinants were cultured overnight at 37 °C
in a humidiﬁed chamber (5% CO2/95% air) in medium consisting of
Neurobasal Media (Invitrogen) supplemented with B27 serum-free
supplement (Invitrogen), 200 mM L-Glutamine, and 1:1000 penicillin
and streptomycin and then ﬁxed in 4% PFA at 4 °C overnight. Explants
were analyzed by in situ hybridization for expression of chick Wnt8a
(Hume and Dodd, 1993).
Results
Conditional alleles enable efﬁcient generation of Fgf3/Fgf10 double null
embryos for isolation and microarray analysis of prospective otic
ectodermal RNA
To enable conditional or global deletion of Fgf3 and/or Fgf10, we
generated targeted alleles in which the 104 bp exon 2 of each gene
was ﬂanked by loxP sites (Fig. 1A; “c” alleles). Single or double homo-
zygous conditional animals were normal (data not shown). In each
case, germline deletion of exon 2 yielded a null allele (designated Δ2
or –, for brevity), and the gross phenotypes of homozygous null
animals were indistinguishable from those generated by other means
(Abler et al., 2009; data not shown; Hatch et al., 2007). For efﬁcient
generation of double mutants we crossed Fgf3Δ2/+;Fgf10Δ2/+;HprtCre/
+ females with Fgf3c/c;Fgf10c/c males. Since CRE was deposited into
oocytes, the “c” alleles were deleted to “Δ2” alleles in all offspring,
regardless of whether they inherited HprtCre. Thus, one quarter of the
E10.5 embryos were double heterozygotes (Fgf3Δ2/+;Fgf10Δ2/+) that
had a normal phenotype (Fig. 1B), and one quarterwere double homo-
zygotes (Fgf3Δ2/Δ2;Fgf10Δ2/Δ2) that, as expected, had shortened tails,
lacked limbs, and had little or no otic vesicle development (Fig. 1C). To
evaluate the efﬁcacy of FGF signaling disruption at the otic placode
stage, we stained E8.5 (7–8 somites) control and double mutant
embryos with FGF signaling target genes, Erm and Spry1. Both genes
were normally expressed in a domain that includes, but is larger
than, the prospective otic placode (Fig. 1D,D1,E,E1), and were strongly
Fig. 1. Use of Fgf3 and Fgf10 conditional alleles to produce double null mutants that lack
otic vesicles at E10.5 and FGF/MAPK signaling markers at E8.5. (A) Each targeted
conditional allele has loxP sites (red arrows) ﬂanking exon 2. An FRT site (black arrow)
remains from FLP-mediated removal of a Neo expression cassette. A tetracycline
response element (T) is located upstream of exon 2. CRE-mediated deletion of the
104 bp exon 2 from the conditional (c) alleles generates the null alleles (designatedΔ2).
Thick boxes indicate the sequences included within the targeting vectors; exons are
indicated in green; 5′ and 3′ UTRs in red; introns in black; recombinase recognition
sequences in pink; and the T in blue. The cross generating doublemutants at a frequency
of 25% is indicated below the allele diagrams. (B) E10.5 Fgf3Δ2/+;Fgf10Δ2/+ embryo
shows a normal phenotype. (C) E10.5 Fgf3Δ2/Δ2;Fgf10Δ2/Δ2 embryo lacks limbs and otic
vesicles, and has a shortened tail. Dashed lines demark limbs (ﬂ, forelimb; hl, hindlimb),
tail (t), and otic vesicle (ov) where present. Whole-mount E8.5 (7-somite) embryos
were probedwith FGF signaling indicators, Erm (D) and Spry1 (E). Genotype is indicated
below each embryo. (D1, E1) Transverse sections taken through the placodal region
(planes numbered and indicated with dashed lines in D and E) show otic placode (op)
expression (arrows) of each gene in double heterozygotes and loss of gene expression in
the corresponding (thin) ectoderm in double mutants (D2, E2, arrows).
Fig. 2. Isolation of tissue and validation by in situ hybridization of microarray candi-
date genes down-regulated in placodal ectoderm of Fgf3/Fgf10-deﬁcient embryos.
(A) Schematic depiction of microdissection of the placodal region of an E8.5 5–8 somite
embryo. Embryos were ﬁrst bisected along the midline (vertical dashed line). The
dorsal, presumptive otic region, was isolated from the ventral aspect with a second cut
(horizontal dashed line), generating two fragments containing neural tube (nt),
placodal ectoderm (ec), and mesendoderm (m, en). (B) Protease treatment of each
hemisected otic region released the mesendoderm from the neural tube and attached
placodal ectoderm, which was then severed from the nt and recovered for RNA
extraction. (C–G) 7–8 somite Fgf3Δ2/+;Fgf10Δ2/+ (3−/+;10−/+) and Fgf3Δ2/Δ2;Fgf10Δ2/
Δ2 (3−/−;10−/−) embryos hybridizedwith riboprobes forHmx3 (C), Foxg1 (D), Sox9 (E),
Has2 (F), and Slc26a9 (G). Anterior is to the top. Transverse sections taken through the
placodal region (planes numbered and indicated with dashed lines in panels C–G) show
otic placode (op) expression of each gene in double heterozygotes (C1–G1, black arrows)
and loss of gene expression in the corresponding (thin) ectoderm in double mutants
(C2–G2, red arrows). Carets and arrowheads indicate Fgf-independent expression in
pharyngeal endoderm, neural tube (nt), andmigrating neural crest (mnc), respectively.
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ectoderm (Fig. 1D,D2,E,E2), demonstrating successful disruption of
FGF signaling in the prospective otic domain. Retention of Erm and
Spry1 in the ventral ectoderm of double mutants suggests that this
region continued to receive FGF signals, which could originate from
the ventral ectoderm itself (e.g. Fgf4, see Fig. 3B,B1, below) or from the
pharyngeal endoderm (e.g. Fgf8, (Ladher et al., 2005); Fgf15, (Wright
et al., 2004); or Fgf4, see Fig. 3B,B1, below).
Microarray analysis reveals candidate targets of FGF signaling
Previous studies showed that expression of several otic placode
marker genes, including Pax2, Gbx2, Dlx5, and Pax8, was not detectedin dorsal ectoderm of Fgf3/Fgf10 double null embryos generated
from standard double heterozygous intercrosses (Alvarez et al., 2003;
Wright andMansour, 2003a). To enable amore comprehensive assess-
ment of FGF-regulated otic ectodermal genes we compared gene
expression proﬁles of three pools each of prospective otic ectoderm
microdissected from 4–8 somite Fgf3Δ2/+;Fgf10Δ2/+ and Fgf3Δ2/Δ2;
Fgf10Δ2/Δ2 embryos (Fig. 2A,B). Rank products analysis yielded a list
of 64 unique transcripts signiﬁcantly up-regulated and 28 down-
regulated by at least 1.5-fold in the FGF-deﬁcient ectodermal RNA
pools (Table S1). Technical difﬁculties in perfecting embryo staging
and tissue isolation are likely to account for the high degree of
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genotype, which in turn may account for the small number of genes
ultimately identiﬁed as signiﬁcantly regulated in all three comparisons.
Validation of FGF-dependent ectodermal target genes
To validate candidate down-regulated transcripts we compared
gene expression in Fgf3Δ2/+;Fgf10Δ2/+ and Fgf3Δ2/Δ2;Fgf10Δ2/Δ2 7–8
somite embryos by whole mount in situ hybridization. Hmx3, Foxg1,
Sox9, Has2, and Slc26a9 were all clearly expressed in control otic
ectoderm (Fig. 2C,C1,D,D1,E,E1,F,F1G,G1), but were absent from Fgf3/
Fgf10-deﬁcient dorsal ectoderm (Fig. 2C,C2,D,D2,E,E2,F,F2G,G2) which,
unlike control dorsal ectoderm, failed to thicken. Retention of Foxg1,
Sox9, andHas2 in doublemutant ventral ectoderm (Fig. 2D2,E2,F2) was
consistent with retention of FGF signaling indicators in this region.
Other sites of gene expression (e.g. pharyngeal endodermal Hmx3,
Foxg1, and Has2) were unaffected in double mutants (Fig. 2C1,C2,D1,
D2,F1,F2). Indeed, expression of Sox9 in the neural tube and migrating
neural crest was unaffected in double mutants (Fig. 2E1,E2),
indicative of the high degree of ectodermal target tissue puriﬁcation
achieved by the dissections. We also tested Hmx2 expression and
found that it, too, was absent from dorsal double mutant ectoderm
(data not shown). In contrast, two placode-expressed genes (Cldn4
and Zic4) and one ubiquitously expressed gene (Dusp16) were
unchanged in double mutants (data not shown). Several other
ubiquitously or relatively non-speciﬁcally expressed genes (Runx2,
Sbsn, Yawae, and Gpr83) were not examined in double mutants.
Finally, Kifc1 and Dcc may represent false positives, as neither gene
was expressed in control placodes, but could be detected elsewhere.
Taken together, these results indicate that our strategy of gene
expression proﬁling successfully enriched for otic genes that are
directly or indirectly dependent on FGF signaling, revealing at least
six genes not previously associated with FGF responses in the mouse
otic placode.
Other ectodermal genes regulated by FGF signaling include Fgf4 and Foxi
genes
We next examined the expression of several other potential
targets of FGF signaling in otic placode induction, including Fgf4,
which previous studies showed is expressed in a restricted portion of
the prospective placode in 4–11 somite embryos (Fig. 3A,A1 and
Wright et al., 2003) and Foxi3 and Foxi2, which mark the prospective
otic and non-otic ectoderm, respectively (Fig. 3C,C1,E,E2) (Ohyama
and Groves, 2004). Like the down-regulated candidates identiﬁed in
the microarray screen, Fgf4 expression was absent from the dorsal
ectoderm of 7–8 somite double mutants (Fig. 3B,B1). Interestingly,
although Fgf4 expression was unchanged in ventral double mutant
ectoderm, it appeared up-regulated in pharyngeal endoderm
(Fig. 3B,B1). As endodermal Fgf4 is normally strongly up-regulated
at the 9-somite stage, it is unclear whether this ﬁnding is signiﬁcant,
or merely a result of somite counting ambiguities. Foxi3 expression
was also eliminated from dorsal ectoderm in all ﬁve 4–7 somite stage
double mutant embryos (Fig. 3D,D1), but was only slightly reduced
in the two 8–9 somite stage double mutants examined (not shown).
In contrast, Foxi2 expression was expanded in double mutant
ectoderm in 7–8 somite embryos (Fig. 3F,F1,F2,F3). Furthermore, by
the 11–12 somite stage, when Foxi2 expression was excluded from
the otic cup of control embryos (Fig. 3G,G2), it was expressed
throughout an inappropriately enlarged ectodermal domain in
double mutant embryos (Fig. 3H,H2). Even when a small ventrally
localized otic cup-like structure formed in doublemutants (Fig. 3H2),
some Foxi2 expression encroached into the thickened region,
suggesting that it did not have a true otic character, much like the
microvesicles found previously in older double mutants (Wright and
Mansour, 2003a).FGF signaling is required for hindbrain Wnt8a expression
The expansion of Foxi2 in Fgf3Δ2/Δ2;Fgf10Δ2/Δ2 ectoderm is similar
to the response of head ectoderm when WNT signaling to the Pax2
lineage is blocked by Tg(Pax2-cre) otic conditional ablation of ß-
catenin (Ohyama et al., 2006). Hindbrain WNT signals are implicated
in otic induction (Freter et al., 2008; Ladher et al., 2000; Ohyama et al.,
2006; Park and Saint-Jeannet, 2008). To determine whether FGF sig-
nals function upstream of hindbrain WNT signals during otic induc-
tion, we assayed hindbrain Wnt genes in control and FGF-deﬁcient
mutants.Wnt6 (Fig. 4A) andWnt3a (Fig. 4C)were expressed as early as
the 7-somite stage, and Wnt1 (data not shown) was expressed from
the 12-somite stage in the dorsal neural ectoderm, from which the
neural crest emigrates; however, expression of these threeWnt genes
was unaffected in Fgf3Δ2/Δ2;Fgf10Δ2/Δ2 embryos (Fig. 4B,D;Wnt1 data
not shown). In contrast,Wnt8a, which is expressed in hindbrain rhom-
bomere (r)4 at least as early as the 4-somite stage and diminished
dramatically by the 9-somite stage (Fig. 4E; Bouillet et al., 1996 and
L.D.U. and S.L.M, unpublished), was signiﬁcantly reduced (Fig. 4F,
n=2), or in some cases absent (n=2), in the doublemutants (Table 1).
Hindbrain Wnt8a was also absent from some Fgf3−/−;Fgf10−/+
(Fig. 4H, n=3) and Fgf3−/− embryos (Fig. 4J, n=2). However,
Wnt8a expressionwas normal in all but one Fgf3−/+;Fgf10−/− embryo
(Fig. 4G, n=4) and in all Fgf10−/− embryos (Fig. 4I, n=2), suggesting
that FGF signaling is directly or indirectly required for hindbrainWnt8a
expression, and that Fgf3 plays a more signiﬁcant role in this process
than does Fgf10.
To determine whether WNT receptors are expressed in the pro-
spective otic placode, we surveyed expression of several Fzd genes
and found that Fzd1 is most speciﬁc to the placode (Fig. 4K), but
expression of Fzd8 could also be detected (Fig. 4L).
FGF signaling is sufﬁcient to induce Wnt8a in a chick ectodermal explant
assay
Human FGF19 induces chick Wnt8a in ectodermal explants that
include neural tissue (Ladher et al., 2000). To determine whether
additional otic region FGFs are sufﬁcient to induceWnt8a expression,
we combined rostral, ectodermal isolates from HH stage 4–5 chick
embryos with FGF protein-coated beads in collagen gel culture. The
explants were cultured overnight and then assayed forWnt8a expres-
sion via in situ hybridization (Table 2, Fig. 5). WeakWnt8a expression
was detected in only 1 of 10 explants exposed to control beads. How-
ever, both FGF4- and, to a lesser extent, FGF3-coated beads, induced
expression ofWnt8a (Fig. 5A–C). FGF4 strongly inducedWnt8a nearly
all of the time (11 of 12 explants), whereas FGF3 induced a weak
signal less frequently (4 of 12 explants). In contrast, FGF10 almost
never induced Wnt8a (1 out 12 explants, Fig. 5D).
Discussion
Induction of the mouse otic placode from pre-otic ectoderm
located adjacent to the hindbrain requires FGF3 and FGF10, which are
expressed in the hindbrain and head mesenchyme, respectively. In
the absence of these signals, the otic vesicle either does not form, or
only a small, rudimentary vesicle is induced (Alvarez et al., 2003;
Wright and Mansour, 2003a). Although in some circumstances FGFs
modulate target tissue proliferation and/or survival, in the case of
Fgf3/Fgf10-deﬁcient embryos, these processes are unperturbed in the
prospective otic territory (Wright and Mansour, 2003a). Instead, FGF
signaling controls gene expression within the pre-otic ectoderm, and
the small set of known FGF target genes, identiﬁed serendipitously,
are presumably contained within a larger set of genes that serve as a
molecular blueprint directing the subsequent differentiation of the
otic anlage. Here we identiﬁed and validated additional FGF targets
that are new candidates for genes involved in otic placode induction
Fig. 3. Other placode-expressed genes are differentially affected in Fgf3/Fgf10-deﬁcient ectoderm. Somite-matched E8.5 Fgf3Δ2/+;Fgf10Δ2/+ (3−/+;10−/+) and Fgf3Δ2/Δ2;Fgf10Δ2/Δ2
(3−/−;10−/−) embryoswere hybridizedwith probes for Fgf4 (A,B), Foxi3 (C,D), and Foxi2 (E–H). Anterior is to the left in A–Dand to the right in E–H. Transverse sections taken through
the otic region (planes numbered and indicated with dashed lines in panels A–H) show otic placode (op) expression of each gene in double heterozygotes (A1,C1,E2,G2, black arrows;
red caret indicates lack of expression in pharyngeal endoderm). Fgf4 was absent from dorsal double mutant ectoderm (B1, red arrow), but up-regulated in pharyngeal endoderm
(B1, caret) and Foxi3was absent fromdorsal ectoderm in doublemutants (D1, red arrow). Foxi2 expressionwas expanded both anteriorly (F1) andposteriorly (F3) in 7–8 somite double
mutants, and overall expression in the placodal region was more intense (F2). In 11–12 somite embryos, Foxi2 expression was restricted from the otic cup (oc) in control embryos
(G, G1,G2,G3), whereas Foxi2was present throughout the dorsal ectoderm (ec) in doublemutants (H,H1,H2,H3). The ventrally localized cup-like structure (“oc”), whichmay represent
the precursor to one of the microvesicles occasionally seen in double mutants, showed incomplete clearing of Foxi2 expression (H2).
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addition, we uncovered a mechanism linking FGF and WNT signaling
in series in the reﬁnement of the otic territory (Fig. 6).
Microarray analysis reveals FGF target genes important for inner ear
development
Microarray-based comparison of control and FGF3/10-deﬁcient
ectoderms revealed a relatively small set of up- and down-regulated
FGF target gene candidates, with theoretical changes in expression
of between 1.5- and 4-fold. We attribute the small set size to several
factors, including small differences in staging between embryos that
were subsequently pooled, the variation inherent in the use of micro-
dissection and enzymatic digestions for isolating small tissue sam-
ples, and stochastic differences ampliﬁed in extremely small RNA sets.
Consequently, it is not surprising that previously identiﬁed FGF-
responsive placodal transcription factor genes (including Pax2, Pax8,
Gbx2, and Dlx5) did not appear on the list, which likely represents a
mere “tip of the iceberg”. Given these considerations, it is striking that
six of the nine down-regulated candidate genes evaluated by in situ
hybridization in both genotypes were strongly reduced or completelyabsent speciﬁcally from double mutant ectoderm. It remains to be
determined, of course, whether these genes are directly or indirectly
regulated by the FGFs, but their differential expression cannot be
a trivial consequence of the absence of an otic placode in double
mutants, given that they are expressed (and were evaluated) prior to
placode-thickening.
Three transcription factor genes (Hmx3, Hmx2, and Foxg1) shown
previously to be required for otic morphogenesis are FGF dependent
and fall within this class. Targeted single and double mutagenesis of
the tandemly duplicated Hmx3 andHmx2 genes revealed that they are
required for normal vestibular development in mice (Hadrys et al.,
1998; Mennerich et al., 1999; Wang et al., 2001, 2004; Wang and
Lufkin, 2005; Wang et al., 1998). In addition, some patients with
hemizygous deletions encompassing HMX2 and HMX3 present with
vestibular dysfunction, congenital sensorineural hearing loss, and
inner ear malformations, implicating these genes in human, as well
as mouse, inner ear development (Miller et al., 2009). However, the
abnormalities described are more consistent with roles in otic vesicle
morphogenesis than in otic placode induction. A third member of
this gene family, Hmx1, is expressed in the developing otic vesicle
(Munroe et al., 2009; Yoshiura et al., 1998), but apparently has no
Fig. 4. Wnt8a is the only hindbrain Wnt that is dependent on Fgf3 and Fgf10 ex-
pression, and the otic ﬁeld expresses at least two WNT receptor (Fzd) genes. Somite-
matched E8.5 control Fgf3Δ2/+;Fgf10Δ2/+ (3−/+;10−/+; A,C,E) and Fgf3Δ2/Δ2;Fgf10Δ2/Δ2
(3−/−;10−/−; B,D,F) embryos were hybridized with probes for Wnt6 (A,B), Wnt3a
(C,D), and Wnt8a (E,F). Wnt6 and Wnt3a were expressed in control neural plates
(A,C), and expression was unchanged in double mutant embryos (B,D). r4 expression
ofWnt8a (E) was reduced or absent (F) in all four double mutants. Fgf3+/Δ2;Fgf10Δ2/Δ2
(3+/−;10−/−; G) and Fgf10Δ2/Δ2 (10−/−; I) embryos showed normal levels ofWnt8a in
4/5 and 4/4 embryos respectively. In contrast, Fgf3Δ2/Δ2;Fgf10+/Δ2 (3−/−;10+/−; H)
and Fgf3Δ2/Δ2 (3−/−; J) showed reduced Wnt8a expression in 3/6 and 2/4 embryos
respectively. WNT receptor genes Fzd1 (K) and Fzd8 (L) were expressed in the otic
placode (op).
Table 2
FGFs induce Wnt8a expression in chick explant culture.
Beads Wnt8a pos./total Wnt8a ++ Wnt8a + Wnt8a −
Control 1/10 0 1 9
FGF4 11/12 10 1 0
FGF3 4/12 0 4 8
FGF10 1/12 0 1 11
++=strong expression.
+=weak expression.
−=no expression.
Explants of chick HH stage 4–5 rostral ectoderm were cultured in the absence (control)
or presence of FGF protein-soaked beads and assayed for chick Wnt8a expression. The
fraction of all explants showing any Wnt8a expression is indicated in the ﬁrst column,
and the number of explants exhibiting strong (++), weak (+), or no (−) expression of
Wnt8a is indicated is indicated in subsequent columns.
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expressed in the placode, then triple mutant analysis with Hmx2 and
Hmx3 could reveal a role for these genes in otic placode induction.
Interestingly, consistent with our ﬁndings of FGF responsiveness
of Hmx2 and Hmx3 during otic placode induction, ectodermal Nkx5.1
(Hmx3) is also down-regulated in zebraﬁsh Fgf8 (ace)mutants (AdamskaTable 1
Wnt8a expression in r4 at 5–8 somites depends on Fgf expression.
Genotype
Wnt8a
expression
(r4)
3−/+;
10−/+
control
3−/−;
10−/−
3−/−;
10−/+
3−/+;
10−/−
3−/+
control
3−/
−
10−/+
control
10−/−
Normal 4 0 3 4 3 2 4 2
Reduced 0 2 0 1 0 0 0 0
Absent 0 2 3 0 0 2 0 0
Total 4 4 6 5 3 4 4 2
5–8 somite mouse embryos of the indicated genotypes were hybridized with theWnt8a
probe and subjectively scored for the intensity of r4 labeling as normal, reduced, or
absent. The number of embryos in each category is indicated.et al., 2000) and otocyst-expressedHmx2 andHmx3 are down-regulated
in SU-5402-treated zebraﬁsh embryos (Feng and Xu, 2010).
Foxg1, another otic placode-expressed transcription factor gene
identiﬁed in our microarray study, is also expressed in and required
for normal morphogenesis, as well as for innervation of the vestibu-
lar system (Hwang et al., 2009; Pauley et al., 2006). The Foxg1−/−
abnormalities are related to, but much milder than the Fgf10−/−
vestibular defects, suggesting that Foxg1may be directly or indirectly
regulated by FGF signaling during otic vesicle morphogenesis, similar
to its behavior during placode induction.
Sox9, which encodes an SRY-box transcription factor, was also
strongly down-regulated in Fgf3−/−;Fgf10−/− mutants. Sox9 is re-
quired for otic placode speciﬁcation in Xenopus and zebraﬁsh (Liu
et al., 2003a; Saint-Germain et al., 2004) and its expression is clearly
dependent upon FGF signaling; it is down-regulated both in Fgf3 and
Fgf8-deﬁcient zebraﬁsh otic ectoderm (Liu et al., 2003a) and Fgf3 and
Fgf10-deﬁcient mouse otic ectoderm (this study). Importantly, Sox9
otic conditional mutants show normal otic placode induction, but the
next step of otic development, namely, placode invagination to form a
cup, fails (Barrionuevo et al., 2008). Thus, our differential expression
screen is clearly capable of identifying FGF-regulated genes that are
critical for both otic placode and vesicle morphogenesis.
Only two validated target genes, Has2 and Slc26a9, do not encode
transcription factors. Has2 encodes hyaluronan synthase-2, which
catalyzes the synthesis of hyaluronan, an extracellular glycosami-
noglycan. In Xenopus inner ears, hyaluronan is found in the space
between themesenchyme and the axial protrusions of otic epithelium
that eventually fuse to form the semicircular canals, where it serves
as a propellant in the fusion process (Haddon and Lewis, 1991).
Although the mechanism of semicircular canal formation differsFig. 5. FGF4 or FGF3, but not FGF10, induces Wnt8a in chick ectodermal explants. HH
stage 4–5 ectodermal explants were cultured with control or FGF protein-coated beads,
and Wnt8a expression was assessed by in situ hybridization. Control beads (A) were
unable to induceWnt8a,whereas FGF4 induced robust expression ofWnt8a (B, arrows)
and FGF3 induced weakWnt8a expression in approximately 1/3 of the explant cultures
(C, arrow). In contrast, FGF10 did not induceWnt8a (D). See Table 2 for quantiﬁcation of
the results.
Fig. 6. Model for induction and resolution of the otic placode from pre-otic ectoderm. (A) Oblique view of a pre-placodal-stage embryo illustrating the initiation of placode
speciﬁcation by hindbrain-expressed FGF3 (light blue) and mesenchyme-expressed FGF10 (gray) acting on the pre-otic ﬁeld (pink) to induce gene expression (data from this and
previous studies). Both FGFs are also required for induction and/or maintenance of hindbrain Wnt8a (dark blue); FGF3 being the more potent activator. (B) Oblique view of a
placodal-stage embryo showing the proposed role of WNT8A interacting with FZD receptors, repressing Foxi2 and limiting otic placode fate to hindbrain-proximal ectoderm, with
remaining ectoderm (yellow) assuming a non-otic fate (epibranchial placode or epidermis).
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are also found in the developingmouse inner ear (McPhee et al., 1987;
Tien and Spicer, 2005). Unfortunately, global Has2−/− mice die too
early to address its roles in semicircular canal formation (Camenisch
et al., 2000). It will be interesting to study semicircular canal mor-
phogenesis using the recently reported Has2 conditional strain
(Matsumoto et al., 2009). Has2−/− embryos do form an otic vesicle;
therefore, Has2 does not seem to be required for placode induction.
A role for Has2 in otic induction could be masked, however, by redun-
dancy with other gene family members (Tien and Spicer, 2005).
Slc26a9, which encodes a chloride channel required for gastric
acid secretion (Dorwart et al., 2008; Xu et al., 2008), has not been
associated previously with otic expression or development. However,
its relatives in the SLC26 family of solute carriers—Slc26a4, encoding
Pendrin, and Slc26a5, encoding Prestin—play critical roles in mouse
ear development and function (Everett et al., 2001; Liberman et al.,
2002) and are mutated in human hearing loss subjects (Everett et al.,
1997; Li et al., 1998; Liu et al., 2003b). Studies of auditory function in
Slc26a9−/− mice are underway.
Expression of MAPK pathway targets, Fgf4, and Foxi genes is altered in
Fgf3−/−;Fgf10−/− mutants
Concomitant with the microarray analysis, we also determined the
FGF responsiveness of pre-otic ﬁeld genes identiﬁed in other studies.
Not surprisingly, common transcriptional targets of the MAPK path-
way mediating FGF signals, Erm and Spry1, were absent from dorsal
double mutant ectoderm. Similarly Fgf4, which is the only Fgf, other
than Fgf3 itself, expressed in the mouse otic placode (McKay et al.,
1996; Wright et al., 2003; Wright and Mansour, 2003a) was also lost
from dorsal ectoderm. This suggests that FGF4 might be required
downstream of FGF3 and FGF10 to maintain or augment the placo-
dal response to FGF3 and FGF10. Mice lacking Fgf4 die during pre-
implantation (Feldman et al., 1995), but Tg(Pax2-cre)-mediated otic
conditional ablation of Fgf4 did not reveal a unique role for this FGF in
otic induction or subsequent function of the inner ear (S. L. Mansour
and E. P. Hatch, unpublished). Therefore, to determine the role of Fgf4
in the otic placode it will be necessary ﬁrst to generate a conditional
Fgf3–Fgf4 deletion allele, as these Fgf genes are located within 20 kb of
one another.
Foxi1 is a master regulator of otic development in zebraﬁsh, and
appears to function in a pathway parallel to that of FGF signaling
(Hans et al., 2007; Solomon et al., 2004). Mouse Foxi1 is expressed andrequired at a later stage of inner ear development (Hulander et al.,
2003), however, the expression patterns of mouse Foxi family mem-
bers, Foxi3 and Foxi2, coincide spatiotemporally with the period of otic
induction. Foxi3 is expressed in a broad ectodermal region beginning
at E6.5, well before otic induction, and is maintained until approx-
imately the 8-somite stage, when it starts to be down-regulated in the
placode (Ohyama and Groves, 2004). Foxi3 was virtually absent from
the dorsal ectoderm of 4–7 somite Fgf3−/−;Fgf10−/− embryos, but
could be detected in 8–9 somite double mutants, suggesting that in
the mouse, there are both FGF-dependent and independent path-
ways of Foxi3 activation. It will be interesting to learn whether mouse
Foxi3 is the functional ortholog of zebraﬁsh Foxi1 in otic placode
induction, but even if so, there are clearly differences between the two
species with respect to the relationship between Foxi1/3 genes and
FGF signaling.
FGF signaling is required not only to specify the pre-otic domain, but also
to regulate the WNT signaling that restricts the otic placode to dorsal
ectoderm
Foxi2 is initially expressed throughout the cranial ectoderm, in-
cluding in the presumptive placode and more ventral ectoderm
that is fated to become epibranchial placode or epidermis, but is
subsequently excluded from the dorsal ectoderm as otic placode
fate is speciﬁed. Exclusion is particularly evident by 11-somites as
the placode thickens in preparation for invagination (Ohyama and
Groves, 2004). The expanded domain of ectodermal Foxi2 expression
we found in 7–8 somite Fgf3−/−;Fgf10−/−mutants, and the failure of
the hindbrain proximal ectoderm to extinguish Foxi2 expression at
11–12 somites is similar to the behavior of Foxi2 when WNT signal
reception in the ectoderm is blocked by Tg(Pax2-cre)-mediated otic
conditional ablation of ß-catenin (Ohyama et al., 2006). Since WNT
signals, presumably emanating from the hindbrain, have long been
implicated in otic induction (Freter et al., 2008; Ladher et al., 2000;
Ohyama et al., 2006; Park and Saint-Jeannet, 2008), this result sug-
gested that FGF signaling might control the WNT signal that restricts
the otic domain. Indeed, we found that FGF signaling is required for r4
expression of Wnt8a, the only hindbrain-expressed gene affected
among those tested here and previously (Wright and Mansour,
2003a), suggesting that WNT8A is the signal, or a component of the
WNT signal, that restricts the otic placode to the hindbrain proxi-
mal portion of the Pax2-positive pre-otic ﬁeld. We also found that
Wnt8a expression was reduced or absent in some Fgf3−/−;Fgf10−/+
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bryos, suggesting that Fgf3maybe themain regulator ofWnt8a (Fig. 6).
Furthermore, our chick explant studies showed that FGF3 and, more
potently, FGF4, were able to induceWnt8a expression, whereas FGF10
was not. Taken together with the mouse loss of function data, these
results show that FGF3 is both necessary and sufﬁcient for Wnt8a
expression, whereas FGF4 is sufﬁcient but not uniquely necessary,
and FGF10 is necessary but not sufﬁcient. Preliminary data suggest
that this FGF/WNT regulatory pathway is unidirectional, as r5–r6
expression of Fgf3 was unperturbed in embryos with Tg(Wnt1-cre)-
mediated conditional deletion of ß-catenin (S. L. Mansour and E. P.
Hatch, unpublished).
Canonical WNT/ß-catenin signaling relies on activation of Frizzled
(Fzd) receptors (Angers and Moon, 2009; MacDonald et al., 2009; van
Amerongen and Nusse, 2009) and consistent with this expectationwe
found two Fzd genes that are expressed in the prospective otic terri-
tory. Within the caudal cranial region, Fzd1 was exclusive to the otic
placode, whereas Fzd8 was more widely expressed but was strongest
within the otic domain. In chick, Fzd1, Fzd2, and Fzd7 are expressed
at otic placode and otic vesicle stages (Sienknecht and Fekete, 2009;
Stark et al., 2000), suggesting roles, at least for Fzd1, in otic devel-
opment. Genetic loss-of-function analyses will be necessary to test
the roles of Wnt8a and the Fzd genes in the restriction of the otic
placode.
FGFs and WNTs have interactive roles at multiple stages of inner
ear development. Otic induction is initiated by FGF signaling, with
WNT limiting the ﬁnal otic domain (Freter et al., 2008; Ladher et al.,
2000; Ohyama et al., 2006; Park and Saint-Jeannet, 2008; this study;
Whitﬁeld and Hammond, 2007). In contrast, the ﬁrst stage of otic
vesicle morphogenesis (outgrowth of the endolymphatic duct) is
initiated by WNT signaling and reﬁned and maintained by FGF signal-
ing (Hatch et al., 2007; Riccomagno et al., 2005). At later stages of
inner ear development, non-canonical WNT signaling regulates the
patterning of the cochlear sensory epithelium (Dabdoub and Kelley,
2005; Qian et al., 2007; Yamamoto et al., 2008), and FGF signaling
directs outgrowth and morphogenesis of the semicircular canals
(Chang et al., 2004; Ohuchi et al., 2005; Pauley et al., 2003). It will be
interesting to learn whether there isWNT-FGF cross-regulation during
either of these two processes.
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